Taurocholic acid has previously been implicated as a promoting factor and biomarker of progression in liver cirrhosis; via the activation of hepatic stellate cells and up-regulation of TLR4 expression in humans62. The gene discussed is TLR4; the disease is cirrhosis of liver.